ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Intensive treatment strategies in patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukemia
Blood Reviews
◽
10.1054/blre.2000.0139
◽
2000
◽
Vol 14
(4)
◽
pp. 182-189
◽
Cited By ~ 8
Author(s):
M. Oosterveld
◽
T. de Witte
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Treatment Strategies
◽
Intensive Treatment
◽
Secondary Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Related Documents
Cited By
References
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
Leukemia
◽
10.1038/sj.leu.2402591
◽
2002
◽
Vol 16
(9)
◽
pp. 1615-1621
◽
Cited By ~ 42
Author(s):
M Oosterveld
◽
◽
P Muus
◽
S Suciu
◽
C Koller
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Prognostic Factors
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Secondary Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
132 RETROSPECTIVE ANALYSIS OF HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AT SAN RAFFAELE SCIENTIFIC INSTITUTE: A SINGLE CENTER EXPERIENCE
Leukemia Research
◽
10.1016/s0145-2126(15)30133-8
◽
2015
◽
Vol 39
◽
pp. S67-S68
◽
Cited By ~ 1
Author(s):
F. Pavesi
◽
C. Messina
◽
M. Carrabba
◽
S. Claudiani
◽
E. Sala
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Retrospective Analysis
◽
Myeloid Leukemia
◽
Allogeneic Transplantation
◽
Single Center
◽
Single Center Experience
◽
Secondary Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment
Case Medical Research
◽
10.31525/ct1-nct04241549
◽
2020
◽
Author(s):
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Intensive Treatment
◽
Newly Diagnosed
◽
Acute Myeloid
Download Full-text
P-18 A new prognostic score foroutcome of patients with high-risk myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (SAML) after intensive antileukemic treatment
Leukemia Research
◽
10.1016/s0145-2126(05)80082-7
◽
2005
◽
Vol 29
◽
pp. S31
◽
Cited By ~ 1
Author(s):
M. Oosterveld
◽
S. Suciu
◽
J.P. Marie
◽
A. Ferrant
◽
P. Muus
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Prognostic Score
◽
Secondary Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)
Case Medical Research
◽
10.31525/ct1-nct03940352
◽
2019
◽
Author(s):
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Faculty Opinions recommendation of Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.10197.467594
◽
2006
◽
Author(s):
Mayumi Mori
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Prognostic Models
◽
Intensive Chemotherapy
◽
Acute Myeloid
Download Full-text
Faculty Opinions recommendation of A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1119427.575617
◽
2008
◽
Author(s):
Arati Rao
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Low Dose
◽
Randomized Study
◽
Front Line
◽
Line Therapy
◽
Low Dose Cytarabine
◽
Acute Myeloid
Download Full-text
A Real Life Turkish Experience Of Venetoclax Treatment In High Risk Myelodysplastic Syndrome And Acute Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/j.clml.2021.04.004
◽
2021
◽
Author(s):
Aliihsan Gemici
◽
Fahir Ozkalemkas
◽
Mehmet Hilmi Dogu
◽
Atakan Tekinalp
◽
Inci Alacacioglu
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Real Life
◽
Acute Myeloid
Download Full-text
Outcome of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome According to Health Insurance Status
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/j.clml.2014.03.003
◽
2014
◽
Vol 14
(6)
◽
pp. 509-513
◽
Cited By ~ 2
Author(s):
Ali Al-Ameri
◽
Ankit Anand
◽
Mohamed Abdelfatah
◽
Zeyad Kanaan
◽
Tracy Hammonds
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Health Insurance
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Insurance Status
◽
Health Insurance Status
◽
Acute Myeloid
Download Full-text
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Leukemia
◽
10.1038/s41375-018-0312-9
◽
2018
◽
Vol 33
(2)
◽
pp. 379-389
◽
Cited By ~ 145
Author(s):
Jorge E. Cortes
◽
Florian H. Heidel
◽
Andrzej Hellmann
◽
Walter Fiedler
◽
B. Douglas Smith
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Low Dose
◽
Newly Diagnosed
◽
Low Dose Cytarabine
◽
Acute Myeloid
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close